Skip to main content
ALLO logo
ALLO
(NASDAQ)
Allogene Therapeutics, Inc.
$2.09-- (--)
Loading... - Market loading

Allogene Therapeutics (ALLO) Stock Price & Financial Analysis

Allogene Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.06 - $2.15
52-Week High$4.46
52-Week Low$1.03
Open$2.12
Volume4.37M
Average Volume (3M)5.81M
Market Cap502.21M
Shares Outstanding240.29M
Price to Book (P/B)1.79
EV/EBITDA-3.31
50-Day MA$1.96
200-Day MA$1.91
52-Week Change90.83%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Allogene Therapeutics

What is the current stock price for ALLO?

As of the latest trading session, ALLO stock trades at $2.09. The 52-week range is $1.03–$4.46, with a day range of $2.06–$2.15.

What is the P/E ratio for ALLO?

The P/E ratio (Price-to-Earnings) for ALLO is shown in the Key Statistics section. This valuation metric helps compare Allogene Therapeutics, Inc. to industry peers.

Does ALLO pay dividends?

Allogene Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALLO?

Based on 1 analyst, the consensus for ALLO is Buy.

What is the market cap of ALLO?

Allogene Therapeutics's market capitalization is $502.2M, classifying it as a small-cap company. Allogene Therapeutics operates in the Healthcare sector within the Biotechnology industry.